Stroke Prevention

The Foundation for Stroke Prevention. Steven Rudolph, MD, Director

[Umberto Pensato @UPensato]

Thromboinflammation in Acute Stroke: From Pathophysiological Challenges to Emerging Therapeutic Opportunities | Stroke @StrokeAHA_ASA @AHAScience https://t.co/IDjWwnoZ24

[Aravind Ganesh @draravindganesh]

🚨In the current landscape of mixed results from MeVO RCTs, we discuss how consideration of occlusion location, vessel size, and stroke severity can inform MeVO treatment decision-making in practice: https://t.co/Nl3EMKpZb0 @mayank_G0 @rondalun1 @johanna_ospel @SVINJournal

[Stroke AHA/ASA @StrokeAHA_ASA]

Biologically informed interventions may complement reperfusion therapies. @UPensato @HUNIMED @UCalgary

https://t.co/ZOERcDPYVd

[Johanna Ospel, MD PhD @johanna_ospel]

#ESCAPEMeVO imaging sub-analysis results are out now👀 check out this @radiology_rsna paper. ➡️Good collaterals are the only prognostic imaging variable and may modify treatment effect. #MeVO #EVT #INR #neurorad #stroke @DCNSNeuro @HotchkissBrain https://t.co/KUsFpcxoMY

[Stroke AHA/ASA @StrokeAHA_ASA]

Device-Detected Atrial Fibrillation in Cryptogenic Stroke: Incidental or Causality?

In this #BloggingStroke post, Beatriz Sarno discusses #Stroke article by @ShadiYaghi2 et al. https://t.co/XZPpzBb21j

[Mica Schachter, MD @neurona_critica]

Practicing Medicine at Life’s Discontinuities
https://t.co/QC37FYKhMS

[Harpreet Bhatia @hsbhatia]

Consistent with prior data showing modest (variable) Lp(a) reduction with PCSK9i

Trend towards greater absolute risk reduction among elevated Lp(a) ppts, results more dramatic for MI:

[Umberto Pensato @UPensato]

24‐Hour CT Infarct Density modified the effect of Infarct Volume on Outcomes and is independently associated with outcomes in #stroke patients treated with IVT within 4.5 hours. @nishita_singh3 @draravindganesh @AlmekhlafiMa @bijoymenon @JAHA_AHA https://t.co/8vE4F8hgvV

[World Stroke Academy @WorldStrokeEd]

#MondayTip

#Early ticagrelor+aspirin after IV thrombolysis may improve 90-day excellent recovery in selected moderate AIS (NIHSS 4–10)
🚶‍♀️mRS 0–1 68.7% vs 62.0%
🩸sICH was rare, but CIs were wide.
☝️Defined phenotype, not broad adoption yet
#TAPIS
🔗https://t.co/OtcXjSKkFF

[JAHA @JAHA_AHA]

Higher amyloid burden in CAA links to hemorrhage-dominant patterns and vascular injury markers on MRI. @GokcalElif @alvindasMD @JRosand_MD @guroledip @SMGreenbergNeur @MGHNeurology https://t.co/dUeYf47O8L

[Shadi Yaghi @ShadiYaghi2]

In this study led by @EkaBakradze1: 1 in 6 patients ultimately diagnosed w cervical artery dissection had a visit within 30 days for neurological symptoms but were not diagnosed at the time. As a reference, in aortic dissection it’s 1 in 3! @StrokeAHA_ASA https://t.co/z8u1zxnwMJ

[journalneurooph @journalneurooph]

Utility of Optical Coherence Tomographic Angiography in Neuro-Ophthalmic Practice: Journal of Neuro-Ophthalmology
Article: https://t.co/qbDTV9onM5
#brain #eye #vision #research #Neurology #NeuroOphth #Ophthalmology

[NEJM @NEJM]

Among patients with stroke due to medium-vessel occlusion, thrombectomy led to functional independence at 90 days (in 58.6% of patients, vs. 46.6% with medical management) but also to a higher risk of intracranial hemorrhage. Full ORIENTAL-MeVO trial results: https://t.co/FvyLPQz4CV

Editorial: Endovascular Therapy for Medium-Vessel Occlusion Stroke — Narrowing the Target Population https://t.co/hnLi0DvzuF

[Stroke AHA/ASA @StrokeAHA_ASA]

In an observational study derived from the UK Biobank, sarcopenia was associated with a higher risk of #stroke and higher mortality among those who suffered a subsequent stroke. https://t.co/6MxgGtJD9P

[Umberto Pensato @UPensato]

Redefining the Cerebral Ischemic Core-Penumbra-Oligemia Continuum @StrokeAHA_ASA @johanna_ospel @draravindganesh @nishita_singh3 @AlmekhlafiMa @BroocksGabriel @Libero131087 @DGutierrez__V @NguyenThanhMD @VYogendrakumar @ZiniAndrea @KimBJstroke https://t.co/QmPTYNtaPt

[NEJM @NEJM]

Cerebral amyloid angiopathy, caused by beta-amyloid deposition in brain blood vessels, leads to lobar cerebral hemorrhage, microbleeds, and white-matter lesions and contributes to cognitive decline.

Learn more in the Review Article “Cerebral Amyloid Angiopathy” by Steven M. Greenberg, MD, PhD, from Massachusetts General Hospital (@MassGeneralNews) and @harvardmed: https://t.co/dEMf0G2Nky

Read a clinical case of a patient with cerebral amyloid angiopathy: https://t.co/Q3Otm9lH9q

[Stroke AHA/ASA @StrokeAHA_ASA]

#STROKE: Simultaneous publication at #ESOC2026 🔴🔵: In RASUNOA-Prime prospective multicentric study, atherosclerosis represents a frequent comorbidity in patients with breakthrough strokes, which may contribute to their high risk of recurrence. https://t.co/Segn79VWJ4

[Johns Hopkins Neuroradiology @hopkinsneurorad]

😵‍💫

[Stroke AHA/ASA @StrokeAHA_ASA]

In adults ≥80 years, embolic ischemic #stroke is more common than thrombotic one, and this association is largely mediated by AFib and other cardiac factors. Adding embolic risk factors substantially improves stroke prediction. https://t.co/MNzCGREhbS

[Stroke AHA/ASA @StrokeAHA_ASA]

#Stroke Comments and Opinions by Howard et al. outlines key design attributes of the CREST-2 trial and how challenges were overcome. @JamesMeschia @ThomasBrott https://t.co/mdTSzWIst3